International Journal of Diabetes and Clinical Research 2022
Top Research Directions
The 3 research directions with International Journal of Diabetes and Clinical Research 2022 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.
| # | Direction | Papers | Share |
|---|---|---|---|
| 1 | Methodological Quality Inheritance in Evidence Synthesis | 1 | 100.0% |
| 2 | Remodeling the Hostile Microenvironment of Diabetic Wounds | 1 | 100.0% |
| 3 | Standardized Frameworks for Assessing Risk of Bias | 1 | 100.0% |
Download all directions as CSV
Institutions
Institutions credited by International Journal of Diabetes and Clinical Research 2022 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 1 credited papers.
| # | Institution | Papers | Share |
|---|---|---|---|
| 1 | 02h8a1848 | 1 | 100.0% |
| 2 | 04jnrse34 | 1 | 100.0% |
| 3 | Queensland University of Technology | 1 | 100.0% |
Download all institutions as CSV
About this data
Papers. International Journal of Diabetes and Clinical Research 2022 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.
Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.
Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “International Journal of Diabetes and Clinical Research 2022”, https://lacuna.tiptreesystems.com/venue/international-journal-of-diabetes-and-clinical-research/2022.
Papers
| Title |
|---|
| Epidermal Growth Factor Outperforms Placebo in the Treatment of Diabetic Foot Ulcer: A Meta-Analysis |